Oncology/Hematology Market Research Reports & Industry Analysis
Oncology/Hematology Industry Research & Market Reports
-
Drug Discovery Services Market by Process (Target Selection, Validation, Hit-to-lead), Type (Chemistry, Biology), Drug Type (Small molecules, biologics), Therapeutic Area (Oncology, Neurology) End User (Pharma, Biotech) - Global Forecast to 2026
... services market is projected to reach USD 31.4 billion by 2026 from USD 16.1 billion in 2021, at a CAGR of 14.3% during the forecast period of 2021 to 2026. Growing R&D expenditure in the ... Read More
-
Cancer Immunotherapy Market Forecasts to 2028 – Global Analysis By Application (Blood Cancers, Ovarian Cancer, Pancreatic Cancer, Liver Cancer), End User (Hospitals & Clinics, Ambulatory Surgical Centres) and By Geography
... Global Cancer Immunotherapy Market is accounted for $119.39 billion in 2021 and is expected to reach $337.42 billion by 2028 growing at a CAGR of 16.0% during the forecast period. Cancer immunotherapy is a cancer ... Read More
-
Prostate Health Market Share, Size, Trends, Industry Analysis Report, By Disease Indication (Prostate Cancer, Benign Prostate Hyperplasia (BPH), Prostatitis); By Modality (Diagnosis, Treatment); By Treatment (Surgery, Radiation Therapy, Therapeutics); By Region; Segment Forecast, 2022 - 2030
... 2030 The global prostate health market size is expected t-reach USD 68.0 billion by 2030, according t-a new study by Polaris Market Research. The report “Prostate Health Market Share, Size, Trends, Industry Analysis Report, By ... Read More
-
Colorectal Cancer - Pipeline Insight, 2022
... stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered • Global coverage Colorectal Cancer ... Read More
-
Metastatic Colorectal Cancer - Market Insight, Epidemiology And Market Forecast - 2032
... States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The mCRC market report provides current treatment practices, emerging drugs, mCRC market share of the individual therapies, current and forecasted mCRC market Size from ... Read More
-
Oncolytic virus cancer therapy - Pipeline Insight, 2022
... including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered • ... Read More
-
Metastatic Castration-Sensitive Prostate Cancer (mCSPC) - Market Insight, Epidemiology And Market Forecast - 2032
... United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The mCSPC market report provides current treatment practices, emerging drugs, mCSPC market share of the individual therapies, current and forecasted mCSPC market Size ... Read More
-
CAR T - Pipeline Insight, 2022
... It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered • Global coverage CAR-T Understanding CAR-T: Overview ... Read More
-
Fallopian tube cancer - Pipeline Insight, 2022
... and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered • Global coverage ... Read More
-
Europe Breast Cancer Screening Market, Forecast 2022-2027, Industry Trends, Share, Insight, Growth, Impact of COVID-19, Company Analysis
... most typical cause of cancer-related mortality among women in Europe. It is more prevalent in European countries due to its modernized lifestyle; late pregnancies, high intake of alcohol because of these factors breast cancer incidence ... Read More
-
Intratumoral Cancer Therapy Market, Size, Global Forecast 2022-2027, Industry Trends, Growth, Impact of COVID-19, Company Analysis
... the highest cause of death; with 19,292,789 new cancer cases were diagnosed and around 9,958,133 cancer death happened in the year 2020. Nevertheless, over the past years, the treatment paradigm of cancer has transformed with ... Read More
-
China Oncology Drugs Market, Size, Forecast 2022-2027, Industry Trends, Growth, Impact of COVID-19, Opportunity Company Analysis
... areas, with patients experiencing a significant health burden. Hence, the cancer drugs industry is the fastest-growing central therapeutic area in China’s pharmaceutical market. In particular, the increasingly challenging treatment of complex, severe cancerous diseases through ... Read More
-
Metastatic Colorectal Cancer - Epidemiology Forecast - 2032
... France, and United Kingdom), and Japan. Geography Covered The United States EU5 (Germany, France, Italy, Spain, and the United Kingdom) Japan Study Period: 2019-2032 Metastatic Colorectal Cancer mCRC Understanding The DelveInsight’s mCRC epidemiology report gives ... Read More
-
Metastatic Castration-Sensitive Prostate Cancer - Epidemiology Forecast - 2032
... Italy, France, and United Kingdom), and Japan. Geography Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Metastatic Castration-Sensitive Prostate Cancer (mCSPC) Disease Understanding ... Read More
-
Ambulatory IV Infusion Pumps Global Market Opportunities And Strategies To 2030: COVID-19 Growth And Change Including: 1) By Therapy: Anti-Infective Infusion Pumps; Chemotherapy Infusion Pump; Others 2) By Patient Care Settings: Hospitals; Home Healthcare; Others 3) By Application: Chemotherapy/Oncology; Diabetes; Gastroenterology; Analgesia/Pain Management; Pediatrics/Neonatology; Hematology; Other Applications Covering: Baxter International; B. Braun Holding GmbH & Co. KG; Becton, Dickinson and Company
... the global ambulatory iv infusion pumps market as it emerges from the COVID 19 shut down. Reasons to Purchase Gain a truly global perspective with the most comprehensive report available on this market covering 12 ... Read More
-
Colombia Gastric Cancer Drugs Market - Industry Trends and Forecast to 2029
... new market report contains data for the historic year 2020, the base year of calculation is 2021 and the forecast period is 2022 to 2029. Market Segmentation: Colombia Gastric Cancer Drugs Market, By Type (Adenocarcinoma, ... Read More
-
Hematology Drugs Global Market Opportunities And Strategies To 2030: COVID-19 Impact and Recovery Including: 1) By Type: Hemophilia; Blood Products; Anemia and Other Blood Disorder Drugs 2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies/Drug Stores; Others 3) By Route Of Administration: Oral; Parenteral 4) By Drug Classification: Branded Drugs; Generic Drugs 5) By Mode Of Purchase: Prescription-Based Drugs; Over-The-Counter Drugs Covering: Takeda Pharmaceutical Company; Roche Holding AG; Amgen Inc.; Novartis AG; Novo Nordisk A/S; Daiichi Sankyo Company
... hematology drugs market as it emerges from the COVID 19 shut down. Reasons to Purchase Gain a truly global perspective with the most comprehensive report available on this market covering 48+ geographies. Understand how the ... Read More
-
Monoclonal Antibodies Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Source (Human, Humanized, Chimeric, and Murine), Production Method (In-Vitro and In-Vivo), Indication (Cancer, Autoimmune Diseases, Infectious Diseases, Inflammatory Diseases, Microbial Diseases, and Others), Application (Therapeutic Applications, Diagnostic Applications, and Research Applications), and End-User (Hospitals, Others, and Research Institutes)
... Others), Application (Therapeutic Applications, Diagnostic Applications, and Research Applications), and End-User (Hospitals, Others, and Research Institutes) The monoclonal antibody market is projected to reach US$ 243.05 billion by 2028 from US$ 111.01 billion in 2021; ... Read More
-
Cervical Cancer - Epidemiology Forecast to 2030
... uterus (Mayo Clinic, 2021). All women are at risk for cervical cancer. It occurs most often in women ages 30 years and older (Centers for Disease Control and Prevention, 2021). Long-lasting infection with certain types ... Read More
-
U.S. Veterinary Oncology Market Size, Share & Trends Analysis Report By Therapy (Surgery, Radiology, Chemotherapy, Immunotherapy), By Animal Type (Canine, Feline), And Segment Forecasts, 2022 - 2030
... expected to expand at a CAGR of 8.7% from 2022 to 2030. The increasing prevalence of cancer in pets, willingness to spend on them by pet owners, and use of canines as a model for ... Read More
-
India Immuno-Oncology Drugs Market, by Drug Type (Immune Checkpoint Inhibitors (Nivolumab, Atezolimumab, Pembrolizumab, Durvalumab), Monoclonal Antibodies (Rituximab, Trastazumab, Bevacizumab , Nimotuzumab, Pertuzumab, Ado-Trastuzumab Emtansine ), and Cancer Vaccines (Gardasil, Cervarix), by Cancer Type (Lung Cancer, Blood Cancer, Breast Cancer, Ovarian Cancer, Cervical Cancer, Colorectal Cancer, Stomach Cancer, Head & Neck Cancer, and Others), and by Distribution Channel (Online Pharmacies, Retail Pharmacies, and Hospital Pharmacies) - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028
... Blood Cancer, Breast Cancer, Ovarian Cancer, Cervical Cancer, Colorectal Cancer, Stomach Cancer, Head & Neck Cancer, and Others), and by Distribution Channel (Online Pharmacies, Retail Pharmacies, and Hospital Pharmacies) - Size, Share, Outlook, and Opportunity ... Read More
-
Global Cancer Survivorship Care Growth Opportunities
... States favors the cancer survivorship care market in the country. Several health IT companies are considering the use of electronic health records (EHRs) or cancer treatment systems for cancer survivors. The use of patient-reported outcomes ... Read More
-
U.K. Cell and Gene Therapy Research Challenges Market, by Therapy Type (Cell Therapy (Stem Cells, T Cells, Dendritic Cells, and NK Cells) and Gene Therapy (Germline Gene Therapy and Somatic Gene Therapy)), and by Indication (Dermatology, Musculoskeletal, Oncology, Immunology, Cardiology & Neurology, and Others) - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028
... (Dermatology, Musculoskeletal, Oncology, Immunology, Cardiology & Neurology, and Others) - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028 Cell therapy can be defined as the transfer of new cells into a patient’s body to ... Read More
-
Immune Checkpoint Inhibitors Market by Type (PD-1 Inhibitors, PD-L1 Inhibitors and CTLA-4 Inhibitor) and Application (Lung Cancer, Bladder Cancer, Melanoma, Hodgkin lymphoma and other application): Global Opportunity Analysis and Industry Forecast, 2021-2030
... checkpoint inhibitors market was valued at $29,803.71 million in 2020, and is projected to reach $1,40,890.10 million by 2030, registering a CAGR of 16.8% from 2021 to 2030 Checkpoint inhibitor is a type of drug ... Read More
-
Global Peptide and Anticoagulant Drug Market Size study, by by product (Hormonal, Antibiotic, ACE Inhibitor, Antifungal, Others) by Application (Diabetes, Infectious Diseases, Cancer, Osteoporosis, Cardiology, Gynaecology, Other Applications) and Regional Forecasts 2021-2027
... Anticoagulant Drug Market is valued at approximately USD XX billion in 2020 and is anticipated to grow with a healthy growth rate of more than 3.3% over the forecast period 2021-2027. Peptides are a specific ... Read More
Research Assistance
